StockDrifts LogoStockDrifts

CTC Bio 060590

Company
씨티씨바이오CTC Bio
Insiders
0
Buys
0
Total Value
Avg Return
Last Filing
2025-10-27

CTC Bio (060590) has 0 disclosed insider purchases and 0 disclosed disposals on record, filed by 0 distinct insiders. The earliest filing StockDrifts holds for CTC Bio is dated 2025-01-23; the most recent is 2025-10-27. All of it is parsed from DART D001/D002 insider disclosures, the official disclosure system operated by the Financial Supervisory Service (Korea).

Price & insider activity (12 months)

Recent insider trades

DateTypeSourceInsiderPositionSharesPrice at filingReturnValue
2025-10-27BUY장외매수
바이오노트
bionote
-2.6M₩5,340-18.9%₩13.7B ($9.5M)
2025-10-27SELL장외매도
파마리서치
Pharma Research
--2.6M₩5,340+18.9%₩13.7B ($9.5M)
2025-04-15BUY장외매수
파마리서치
Pharma Research
-700.0K₩7,100-39.0%₩5.0B ($3.5M)
2025-04-15BUY시간외매매
파마리서치
Pharma Research
-252.7K₩7,100-39.0%₩1.8B ($1.2M)
2025-04-10BUY장외매수
바이오노트
bionote
-763.7K₩6,630-34.7%₩5.1B ($3.5M)
2025-04-10BUY장외매수
바이오노트
bionote
-812.0K₩6,630-34.7%₩5.4B ($3.7M)
2025-01-23BUY장외매수
바이오노트
bionote
-1.4M₩7,440-41.8%₩10.6B ($7.4M)
2025-01-23SELL장외매도
이민구
Lee Min-gu
--1.4M₩7,440+41.8%₩10.6B ($7.4M)

Frequently asked questions

Who has been buying CTC Bio stock?
0 distinct insiders have filed 0 disclosed insider purchases in CTC Bio (060590), most recently on 2025-10-27. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.
How many insider filings does CTC Bio have?
CTC Bio has 0 buy-side and 0 sell-side disclosures on record, spanning 2025-01-23 to 2025-10-27.
Where does StockDrifts get CTC Bio insider data?
From DART D001/D002 insider disclosures — the official filing system run by the Financial Supervisory Service (Korea). StockDrifts parses each disclosure and matches it to daily price history; the original filings remain available directly from DART.
Do insider buys in Korean stocks predict returns?
Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean DART filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

Source filings

Every trade listed above is disclosed in DART D001/D002 insider disclosures, filed with the Financial Supervisory Service (Korea). View the original DART filings for CTC Bio. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.